期刊文献+

慢性髓细胞性白血病患者肿瘤细胞表达VEGF受体的研究 被引量:2

Research of Expression the VEGF Recepters in Patients with Chronic Myelocytic Leukemia
下载PDF
导出
摘要 目的:了解慢性髓细胞性白血病患者肿瘤细胞VEGF、b-FGF、KDR、Flt-1基因表达,探讨血管生成因子与肿瘤细胞间的相互作用。方法:用RT-PCR方法检测16例慢性髓细胞性白血病患者骨髓粒系细胞VEGF、b-FGF、KDR、Flt-1基因表达,以5例原发性血小板减少性紫癜患者作对照组进行比较。结果:VEGF和b-FGF基因高表达,与对照组比较有显著差异(P<0.05)。KDR基因基本不表达,Flt-1明显表达但与对照组无明显差异。结论:虽然KDR和Flt-1的表达意义不大,但VEGF和b-FGF基因高表达。证实了肿瘤细胞分泌血管生成因子增加,可能存在自分泌途径。 Objective: We studied the gene expression of VEGF, b-FGF, KDR and Flt-1 in 16 CML pateins in order to acknowledge the reciprocity between Angiogenesis factors and Leukaemia cells. Methods: Myeloid cells were isolated from 16 CML patients as study group and 5 ITP patientsas control group to detect the gene expression of VEGF > b-FGF, KDR and Flt-1. Results: The gene expression of VEGF and b-FGF were both higher than those of control group(P<0. 05). KDR gene was hardly expressed in study group, while Flt-1 were highly expressed in both groups,and the difference has no statistics significance. Conclusion: Although the expression of KDR and Flt-1 genes had no obvious correlation according to our study,the high expression of VEGF and b-FGF genes show that the high secretion of the Angiogenesis factors in leukaemia cells may be caused by outocrine mechanism.
出处 《中国临床医学》 北大核心 2005年第3期506-509,共4页 Chinese Journal of Clinical Medicine
关键词 慢性髓细胞性白血病 血管内皮生长因子 基础成纤维细胞生长因子 受体 Chronic myelocytic leukemia Vascular endothelial growth factor Basic fibroblast growth factor Receptor
  • 相关文献

参考文献14

  • 1Fialkow PJ, Jacobmn RJ, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte plateletand monocyte/macrophage[J]. Am J Med, 1977,63(1):125-130.
  • 2Folkman J. Tumor angiogenesis: therapeutic implications[J]. N Engl J Med, 1971,18,285(21):1182-1186.
  • 3Bussolino F, Alhini A, (hmussi G, et al. Role of soluble mediators in angiogenesis[J]. Eur J Cancer, 1996,32A(14) :2401 2412.
  • 4Toi M, Taniguchi T,YamamotoY, et al. Clinical significance of the determination of angiogenic factors[J]. Eur J Cancer, 1996,32A(14):2513-2519.
  • 5Ferrara N. Vascular endothelial growth factor[J]. Eur J Cancer,1996,32A(14): 2413-2422.
  • 6Keyt BA, Nguyen HV, Berleau LT,et al. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis[J]. J Biol Chem, 1996,271(10) :5638-5646.
  • 7Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms, differential deposition into the subepithelial extracellular matrix and bioaetivity of extracellular matrix-bound VEGFF[J] Mol Biol Ce11,1993,4(12):1317-1326.
  • 8Keyt BA, Berleau LT, Nguyen Hv,et al. The carboxyl-terrninal domain (111 - 165) of vascular endothelial growth factor is critical for its mitogenic potency[J]. J Biol Chem,1996,271(13):7788-7795.
  • 9Shweiki D, Itin A, Softer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis[J].Nature, 1992,359(6398):843-845.
  • 10Forsythe JA, Jiang BH, Iyer NV,et al. Activation of vascular endothelial growth [actor gene transcription by hypoxia-inducible factor 1[J]. Mol Cell Biol, 1996,16(9) :4604-4613.

同被引文献33

  • 1曾东风,孔佩艳,陈幸华,彭贤贵,魏立,常诚,刘林,刘红,王庆余.SDF-1及其受体CXCR4在急性白血病与淋巴瘤表达的初步研究[J].中国实验血液学杂志,2005,13(2):274-277. 被引量:29
  • 2徐喜慧,贺其图,贾国荣,宋芳,赵晓华,徐军.白血病患者骨髓血管新生的研究[J].白血病.淋巴瘤,2005,14(2):80-82. 被引量:9
  • 3Gleichmann M, Gillen C, Czardybon M, et al, Cloning and characterization of SDF-1 gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur J Neurosci, 2000;12:1857 - 1866
  • 4Rombouts EJ, Pavic B, Lowenberg B, et al, Relation between CXCR4 expression , Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia. Blood, 2004 ;104:550 -557
  • 5Psenak O. Stromal cell-derived factor ( SDF-1 ). Its structure and function. Cas Lek Cesk, 2001 ;140:355 -363
  • 6Gupta SK, Pillarisetti K, Thomas RA, et al. Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1: implications for development of selective CXCR4 antagonists. Immunol Lett, 2001 ;78:29 -34
  • 7Nanki T, Lipsky PE. Cutting edge: stromal cell-derived factor-1 is a co-stimulator for CD34 + T cell activation. J Immunol, 2000; 164:5010 -5014
  • 8Wang JF, Park IW, Groopman JE. Stromal cell-drived factor-1α stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. Blood, 2000 ; 95:2505 - 2513
  • 9Hatton K, Heissig B, Tashiro K, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor cells. Blood,2001 ;97:3354 -3360
  • 10Shen H, Cheng T, Olszak I, et al. CXCR4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J Immunol, 2001 ; 166:5027 -5033

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部